Study of VCT220 for people with high blood pressure and obesity
Part of Heart & circulation clinical trials.
This trial tests an investigational drug called VCT220 in adults who have high blood pressure and are overweight or obese. The study will see if VCT220 can help lower blood pressure and support weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your body mass index (BMI) is 24 or higher.
- You have been diagnosed with high blood pressure (systolic at least 140 or diastolic at least 90) and are either not on medication or have been on a stable dose of certain blood pressure drugs for at least 30 days.
- You have tried to lose weight through diet before but were not successful.
- You are willing to follow a regular lifestyle, diet, and exercise routine during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment called CTX340 for high blood pressure that is hard to control even with multiple medications. The study aims to see if it is safe and effective.
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
This trial tests if the weight loss medication tirzepatide can help young adults (18–40) with obesity and high blood pressure lower their blood pressure. It compares standard care to weight loss with tirzepatide.
This study tests a new combination of three medications (THP-00101, THP-00102, and THP-00103) for people with type 2 diabetes and essential high blood pressure. It aims to see if this combination is safe and effective compared to standard treatments.
This early-phase study looks at how the body’s “fight-or-flight” signals may be involved in weight gain (obesity) and high blood pressure. It may help researchers understand the biology and guide future treatments.
This study tests a new medication (TCA108) for people whose high blood pressure is not well controlled despite taking two blood pressure medicines. The goal is to see if TCA108 can safely lower blood pressure further.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.